Our Impact
With the launch of GBM AGILE, a new path has been uncovered—one that accelerates this pace of discovery from bench to bedside, and offers the greatest hope in the fight against cancer. Many important milestones have already been achieved, but there’s so much more on the horizon. Take a look and see how the generous support of our donors is making a difference, one dollar at a time.
Our Progress
Milestones We’ve Achieved Together
60 Trial Sites in the United States
2,300+ Patients Screened
50+ Global Sites Selected
7 Pharmaceutical Partners
In addition to the progress already achieved, the AGILE trial design is making an even greater impact. The AGILE trial approach is being used to combat other rare and deadly diseases.
